Brands and Generics: Criteria for Evaluating the Effectiveness
The article deals with problem of choice in the administration of brands and generics, a review of the literature on the bioequivalence of these drugs is provided.
Main Authors: | V.V. Poltorak, V.V. Lipson |
---|---|
Format: | Article |
Language: | English |
Published: |
Publishing House Zaslavsky
2013-09-01
|
Series: | Mìžnarodnij Endokrinologìčnij Žurnal |
Subjects: | |
Online Access: | http://iej.zaslavsky.com.ua/article/view/84640 |
Similar Items
-
WHAT IS THERAPEUTIC EQUIVALENCE OF GENERIC DRUG AND HOW TO PROVE IT
by: N. P. Kutishenko, et al.
Published: (2016-01-01) -
Evaluation of Bioequivalence of Generic Imatinib Products and Generic Tacrolimus Products Based on Indirect Comparison of the Results of Their Bioequivalence Studies
by: D. V. Goryachev, et al.
Published: (2019-09-01) -
Russian Association of Endocrinologists reports commencement of Amaril clinical use
by: Editorial team Diabetes Mellitus
Published: (2012-03-01) -
Generic drugs: myths, facts, and limitations
by: Antonio Marzo, et al.
Published: (2012-10-01) -
The concept of: Generic drugs and patented drugs Vs brand name drugs and non-proprietary (generic) name drugs.
by: Karan eThakkar, et al.
Published: (2013-09-01)